Pilot Testing Dementia-Enhanced Training and Tool for Home Hospice Clinicians
단계 해당 없음
완료
NCT05719077
| 대상 질환 | Alzheimer's Disease and Related Dementias |
|---|
| 임상 단계 | 단계 해당 없음 |
|---|
| 스폰서 | Rutgers, The State University of New Jersey |
|---|
| 상태 | 완료 |
|---|
| 참여자 수 | 93 명 |
|---|
| 중재(약물) | EDITH-HC |
|---|
| 시작일 | 2023년 10월 6일 |
|---|
| 완료일 | 2025년 6월 30일 |
|---|
| 결과 공개일 | 2026년 7월 16일 |
|---|
요약
The purpose of this study is to pilot test the feasibility, acceptability, and preliminary efficacy of a clinically useful, inclusive dementia-enhanced training and tool for use by home hospice clinicians to improve care and support for Black and White patients with dementia and their family caregivers. The investigators expect family caregivers of clinicians in the intervention group will report less caregiver burden (primary outcome) than caregivers of clinicians in the control group. The investigators expect that, compared to clinicians in the control group (usual care), clinicians in the intervention group (receive the training and use the tool) will demonstrate more knowledge of dementia-related caregiving issues (secondary outcomes). In exploratory analyses, the investigators expect family caregivers will report greater self-efficacy and preparedness, and that patients of clinicians in the intervention group will experience fewer live discharges than family caregivers of patients of clinicians in the control group.
Family Caregiver Burden
Baseline and through first subsequent hospice visit, an average of 8 weeks · change in score on a scale
| Intervention Family Care Partners (FCP) | -1.0 ± 3.5 change in score on a scale |
|---|
| Control Family Care Partners | 0.4 ± 4.6 change in score on a scale |
|---|
BENITIONS에서 보기
ClinicalTrials.gov 원문 보기
같은 질환의 다른 임상
전체 임상
이 페이지는 ClinicalTrials.gov의 공개 데이터를 정리한 것입니다. 의학적 조언이 아니며 투자 권유나 자문도 아닙니다. 반드시 전문의와 상담하세요.